Advanced Therapies Integrates 2022
CELLULAR GROWTH
How do you secure VC investment? This track focuses on how to develop and present your advanced therapy innovation to secure investment.
TECH TO TRANSLATE
Discover the scientific and technological innovations to support your ATMP getting to market.
MAKING IT
Discover how to manufacture your ATMPs, outsourced or in-house, and the process and analytical technology innovation that underpins success.
Registration and Networking
08:00 – 08:50
Registration and Networking
Welcome & Opening Remarks
08:50 – 09:00
Welcome & Opening Remarks
MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult
Fireside Chat
09:00 – 09:20
Fireside Chat
Interviewed by:Â MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult
Fireside Chat
09:20 – 09:40
Fireside Chat
An interview with: NICOLA REDFERN | Consultant | NJ Redfern Ltd
Interviewed by:Â MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult
Session 1
09:45 – 10:35
Viable cells to viable sells
How do you develop an investible opportunity that is commercially viable?
Please join track 1 or 3
Please join Track 1 or 3
Innovate to Elevate
Discover how Process Analytical Technology can improve your ATMP manufacturing and scale up.
Coffee Break
10:35 – 11:10
Networking coffee break
Session 2
11:15 – 12:05
Pitch perfect: advancing therapies
How to present an investible opportunity, focusing on pitching, partnering and funding opportunities.
Please join track 1 or 3
Please join Track 1 or 3
Matchmaking
How to find the right partner to outsource your manufacturing and the considerations for setting up a productive partnership.
Session 3
12:10 – 13:00
VC judges: what is the X factor?
What are VC Investors looking for at different stages of the life cycle? How is the current economic environment impacting Venture Capital?
Please join track 1 or 3
Please join Track 1 or 3
ATMP: house blend
Understand when to keep manufacturing in-house and what you need to consider to make that a success e.g. what expertise and skills are required.
Lunch Break
13:00 – 14:05
Networking lunch break
Session 4
14:05 – 14:55
Please join Track 2 or 3
Please join Track 2 or 3
Advancing through the clinic to market
What do you need to consider to progress advanced therapies through the clinical phase of development?
Oh Industry 4.0
How has Industry 4.0 been adopted and where should the focus be? Our panel discusses digitalisation, sensors and automation, security and sustainability.
Session 5
15:00 – 15:50
Healthy Economics for thriving ATMPs
How do you plan ATMP Health Economics for early-stage R&D, ensuring commercial viability?
Prepare for patients
Identifying the best targets, using AI, BioInformatics and ‘Omics’ approaches to improve biological understanding and predict efficacy and pharmacology for cell and gene therapies.
Please join Track 1 or 2
Please join Track 1 or 2
Closing Remarks
15:50 – 16:00
Closing Remarks
SHARON BROWNLOWÂ | Chief Business Officer | Cell & Gene Therapy Catapult
Drinks Reception
16:00 – 17:00
Networking drinks reception
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.
Advanced Therapies Integrates 2022
Registration and Networking
08:00 – 08:50
Welcome & Opening Remarks
08:50 – 09:00
MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult
Fireside Chat
09:00 – 09:20
An interview with: MARTIN MURPHY | Chief Executive Officer | Syncona Investment Management Limited
Interviewed by:Â MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult
Fireside Chat
09:20 – 09:40
An interview with: NICOLA REDFERN | Consultant | NJ Redfern Ltd
Interviewed by:Â MATTHEW DURDY | Chief Executive Officer | Cell and Gene Therapy Catapult
CELLULAR GROWTH
How do you secure VC investment? This track focuses on how to develop and present your advanced therapy innovation to secure investment.
09:45 – 10:35
Viable cells to viable sells
How do you develop an investible opportunity that is commercially viable?
Coffee break & Networking
10:35 – 11:10
11:15 – 12:05
Pitch perfect: advancing therapies
How to present an investible opportunity, focusing on pitching, partnering and funding opportunities.
12:10 – 13:00
VC judges: what is the X factor?
What are VC Investors looking for at different stages of the life cycle? How is the current economic environment impacting Venture Capital?
Lunch break & Networking
13:00 – 14:05
15:00 – 15:50
Healthy Economics for thriving ATMPs
How do you plan ATMP Health Economics for early-stage R&D, ensuring commercial viability?
Closing remarks
15:50 – 16:00
SHARON BROWNLOWÂ | Chief Business Officer | Cell & Gene Therapy Catapult
Networking drinks reception
16:00 – 17:00
TECH TO TRANSLATE
Discover the scientific and technological innovations to support your ATMP getting to market.
Networking lunch break
13:00 – 14:05
14:05 – 14:55
Advancing through the clinic to market
What do you need to consider to progress advanced therapies through the clinical phase of development to reach the marketplace?
15:00 – 15:50
Prepare for patients
Identifying the best targets, using AI, BioInformatics and ‘Omics’ approaches to improve biological understanding and predict efficacy and pharmacology for cell and gene therapies.
What should you consider when getting an advanced therapy ready for First in Human trials? Does it have the 5Rs: right target, right tissue, right safety, right patient and right commercial potential?
Closing remarks
15:50 – 16:00
SHARON BROWNLOWÂ | Chief Business Officer | Cell & Gene Therapy Catapult
Networking drinks reception
16:00 – 17:00
MAKING IT
Discover how to manufacture your ATMPs, outsourced or in-house, and the process and analytical technology innovation that underpins success.
09:45 – 10:35
Innovate to Elevate
Discover how Process Analytical Technology can improve your ATMP manufacturing and scale up.
Networking coffee break
10:35 – 11:10
11:15 – 12:05
Matchmaking
How to find the right partner to outsource your manufacturing and the considerations for setting up a productive partnership.
12:10 – 13:00
ATMP: house blend
Understand when to keep manufacturing in-house and what you need to consider to make that a success e.g. what expertise and skills are required.
Networking lunch break
13:00 – 14:05
14:05 – 14:55
Oh Industry 4.0
How has Industry 4.0 been adopted and where should the focus be? Our panel discusses digitalisation, sensors and automation, security and sustainability.
Closing remarks
15:50 – 16:00
SHARON BROWNLOWÂ | Chief Business Officer | Cell & Gene Therapy Catapult
Networking drinks reception
16:00 – 17:00
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.